Shortened lung clearance index is a repeatable and sensitive test in children and adults with cystic fibrosis

BMJ Open Respiratory Research

Volumn 1, Issue 1, 2016, Pages

  Hannon, David ^a   Bradley, Judy M ^b   Bradbury, Ian ^b   Bell, Nicholas ^c   Stuart Elborn, J ^a   O’Neill, Katherine ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SULFUR HEXAFLUORIDE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; LUNG CLEARANCE INDEX; MALE; MEASUREMENT REPEATABILITY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 85006662772     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2014-000031     Document Type: Article

References (19)

1. Gustafsson PM, Aurora P, Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003;22:972–9.
2. Horsley AR, Gustafsson PM, Macleod KA, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008;63:135–40.
3. Kent L, Reix P, Innes JA, et al. Lung clearance index: evidence for use in clinical trials in cystic fibrosis. J Cyst Fibros 2014;13:123–38.
4. Davies J, Sheridan H, Bell N, et al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Lancet Respir Med 2013;1:630–8.
5. Subbarao P, Stanojevic S, Brown M, et al. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013;188:456–60.
6. Rowan SA, Bradley JM, Bradbury I, et al. Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis. Am J Respir Crit Care Med 2014;189:586–92.
7. Macleod KA, Horsley AR, Bell NJ, et al. Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease. Thorax 2009;64:33–7.
8. Robinson PD, Latzin P, Verbanck S, et al. Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J 2013;41:507–22.
9. Bouhuys A, van Lennep HJ. Effect of body posture on gas distribution in the lungs. J Appl Physiol 1962;17:38–42.
10. Yammine S, Singer F, Abbas C, et al. Multiple-breath washout measurements can be significantly shortened in children. Thorax 2013;68:586–7.
11. Nielsen N, Nielsen JG, Horsley AR. Evaluation of the impact of alveolar nitrogen excretion on indices derived from multiple breath nitrogen washout. PLoS ONE 2013;8:e73335.
12. Horsley AR, Davies JC, Gray RD, et al. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 2013;68:532–9.
13. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319–38.
14. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages. Am J Respir Crit Care Med 2008;177:253–60.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10.
16. Verbanck S, Paiva M, Paeps E, et al. Lung clearance index in adult cystic fibrosis patients: the role of convection-dependent lung units. Eur Respir J 2013;42:380–8.
17. Verbanck S, Paiva M. Gas mixing in the airways and airspaces. Compr Physiol 2011;1:809–34.
18. Verbanck S, Paiva M, Schuermans D, et al. Relationships between the lung clearance index and conductive and acinar ventilation heterogeneity. J Appl Physiol 2012;112:782–90.
19. Horsley AR, Macleod KA, Robson AG, et al. Effects of cystic fibrosis lung disease on gas mixing indices derived from alveolar slope analysis. Respir Physiolo Neurobiol 2008;162:197–203.